As the Year Comes to a Close, Lipitor Lawsuits Commence

Gabriel A. Assaad
Connect with me
Partner Gabriel Assaad represents victims of negligence and medical malpractice nationwide.
Comments (0)

Since 1996, Lipitor has proven to be one of the best selling drugs of all time. Lipitor is a medication known as a statin. Its purpose is to reduce the risk of heart disease. The medication has remained successful even after the U.S. Food and Drug Administration (FDA) issued expanded warnings relating to the use of statins. Millions of Americans continue to use statins regularly. Unfortunately, the use of Lipitor has also been linked to an increased risk of developing type 2 diabetes. Patients who suffered this harm as a result of taking the drug accuse the drug’s maker, Pfizer, of failing to provide proper warnings and misleading consumers. Lawsuits against the company are now proceeding to trial.

First Bellwether Cases Move to Trial Over Lipitor Injuries

In January 2015, the first bellwether Lipitor trials were selected. If you are unfamiliar with legal terminology, you may be wondering what a “bellwether” trial means. A bellwether trial is a case that the court and the parties select to test their arguments. An Empty Court RoomThe goal of the bellwether trial is to move the litigation towards a resolution. Bellwether trials are used in cases where thousands of people are all injured by the same defective drug, undisclosed side effects, or faulty products. The various lawsuits typically have facts that are similar to the other thousands of cases being filed. As a result, a bellwether trial is selected to help decide whether plaintiffs should continue to pursue litigation to be compensated for their losses or if they should consider settling. If they do want to consider a settlement, the bellwether trials help them to agree on terms. For example, if the bellwether trials result in victories for the plaintiffs, other injured parties may be more likely to hold out for better settlement terms in their own legal action.

To date, nearly 2,500 Lipitor lawsuits have been filed relating to the link between the drug and the development of type 2 diabetes. These lawsuits have been filed in federal court, and many more are expected to follow. The first bellwether case that will go to trial is known as Daniels v. Pfizer. The suit was initially filed in February 2014.

Daniels v. Pfizer: The First Lipitor Case to Go to Trial

Of the thousands of lawsuits that have been filed to date involving the link between diabetes and the use of the drug Lipitor, Daniels v. Pfizer, is the first to go to trial. The case was filed by Wilma Daniels, a woman who claims that Lipitor is defective and unreasonably dangerous. In her complaint, she accused Pfizer of negligent and wrongful conduct. The following is an overview of her claims:

  1. Prior to taking Lipitor, Daniels was a healthy individual with a healthy weight and diet.
  2. Daniels began taking the drug in 1998 in order to reduce her risk of heart disease.
  3. In 2004, Daniels was diagnosed with type 2 diabetes.
  4. As a result of her diabetes, she now faces an increased risk of heart disease, kidney damage, blindness, and nerve damage.

Like many other Lipitor users, Daniels alleges that it was her use of the drug that led to the development of her diabetes. She provided the opinion of a medical professional to support her claim.

Unfortunately for those who have taken Lipitor, type 2 diabetes is not the only potential risk or complication associated with the use of the drug. Other risks include liver damage, memory loss, and potential muscle damage. As a result, it is critical for users of the drug who have suffered injuries to seek protection of their legal rights. If you took Lipitor and suffered a dangerous side effect, you may be entitled to compensation as a result. We encourage you to reach out today for a free consultation at 855-947-0707.


Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.